1-4 of 4
Emmanuel Bissé
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fetal Hemoglobin (HbF) Induction during Initial Decitabine (DAC) Treatment of Elderly High-Risk MDS and AML Patients: A Potential Dynamic Biomarker for Outcome

Julia Stomper, Gabriele Ihorst, Stefan Suciu, Philipp Nikolaus Sander, Heiko Becker, P.W. Wijermans, Emmanuel Bissé, Rainer Claus, Michael Lübbert
Journal: Blood
Blood (2017) 130 (Supplement 1): 4261.
https://doi.org/10.1182/blood.V130.Suppl_1.4261.4261
Published: 2017
Journal Articles

Elevated Pre-Treatment Fetal Hemoglobin Predicts Better Outcome in MDS/AML Patients Receiving 5-Aza-2'-Deoxycytidine (DAC)

Rainer Claus, MD, Gabriele Ihorst, PhD, Philipp Sander, Ljudmila Bogatyreva, Heiko Becker, MD, Pierre W Wijermans, MD, Stefan Suciu, Emmanuel Bissé, MD PhD, Michael Lübbert, MD
Journal: Blood
Blood (2016) 128 (22): 3175.
https://doi.org/10.1182/blood.V128.22.3175.3175
Published: 2016
Journal Articles

Induction of an Erythroid but Not Megakaryocytic Expression Signature in Myeloid Cells By in Vitro 5-Aza-2'-Deoxycytidine Treatment

Rainer Claus, MD, Philipp Sander, Dietmar Pfeifer, PhD, Lioudmila Bogatyreva, Emmanuel Bissé, MDPhD, Michael Lübbert, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4538.
https://doi.org/10.1182/blood.V126.23.4538.4538
Published: 2015
Journal Articles

Hemoglobin F Induction Is Frequent during Low-Dose 5-aza-2′-Deoxycytidine Treatment of Older AML/MDS Patients.

Rainer Claus, MD, Björn Hackanson, MD, Lena Kasten, Björn Rüter, MD, Emmanuel Bisse, MD PhD, Dieter Pfeifer, PhD, Michael Lübbert, MD PhD
Journal: Blood
Blood (2006) 108 (11): 4573.
https://doi.org/10.1182/blood.V108.11.4573.4573
Published: 2006